Wendy Johnson, MD
Family Medicine · Santa Fe, NMNPI 1982648093
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $37,051 of the $37,299 with a category attached, or 99.3%. Gilead accounts for 99.4% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2020 at $37,051 and has fallen 99.8% since, to $76 in 2025. Among family medicine clinicians in NM with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 8 payments — averaging $4662.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gilead$37K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$124
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$31
- Exact Sciences$27
- Alkermes, Inc.$18
- Indivior Inc.$18
Across 26 payments — averaging $8964.07 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Modernatx, Inc.$225K
- Currax Pharmaceuticals LLC$8K
What the payments were for
- Consulting fees$37,05199%
- Food & beverage$2481%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gilead | 2 | $37,081 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $124 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $31 |
| Exact Sciences | 1 | $27 |
| Alkermes, Inc. | 1 | $18 |
| Indivior Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CAPLYTA$124
How this compares
$37,299 in reported general payments places this provider in the 95th percentile of 717 family medicine providers in New Mexico.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Advair HfaFluticasone Propion/Salmeterol | 12 | $5,194 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 50 | $1,781 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 14 | $1,492 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 44 | $1,210 |
| Atorvastatin Calcium | 70 | $921 |
| Oxycodone Hcl | 39 | $884 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 40 | $871 |
| Lisinopril | 71 | $815 |
| Omeprazole | 40 | $622 |
| Gabapentin | 43 | $586 |
| Levothyroxine Sodium | 57 | $551 |
| Losartan Potassium | 45 | $515 |
| Amlodipine Besylate | 48 | $509 |
| Levetiracetam | 15 | $465 |
| Famotidine | 38 | $465 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Santa Fe
- Kurt KastendieckSanta Fe$7K
- Carl FriedrichsSanta Fe$7K
- Luis Rigales IiiSanta Fe$4K
- Aryan CaireSanta Fe$3K
- Debra HigginbothamSanta Fe$3K
- Karla Moya-CritesSanta Fe$3K
- Gerzain ChavezSanta Fe$3K
- Harold McFarlingFarmington$160K
- Carletta BullockAlbuquerque$60K
- Robert BairAlbuquerque$44K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.